跳至主要内容
临床试验/NCT01506908
NCT01506908已完成2 期

Evaluation of the Nicotine Mini Lozenge in Relief of Provoked Acute Craving

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 323 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
323
试验地点
1
主要终点
Change From Post-cue Baseline in Nicotine Craving Score at 5 Minutes

研究概览

简要总结

Evaluation of the ability of a nicotine mini lozenge to provide early relief of craving for a cigarette in smokers

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current cigarette smokers who have smoked regularly, and smoke more than 20 cigarettes per day on a regular basis for at least a year;
  • Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history.

排除标准

  • Any disease that may interfere with the absorption, metabolism or excretion of the study product.
  • A medical condition that might jeopardise the safety of the subject or the validity of the study results. For example, recent myocardial infarction or cerebrovascular incident (within 12 weeks of the screening visit), phenylketonuria, unstable or worsening angina pectoris, Prinzmetals angina or severe cardiac arrhythmia

研究组 & 干预措施

Nicotine Polacrilex mint mini lozenge

Active Comparator

干预措施: oral nicotine (Drug)

placebo

Placebo Comparator

mint mini lozenge with no active

干预措施: Placebo (Drug)

结局指标

主要结局

Change From Post-cue Baseline in Nicotine Craving Score at 5 Minutes

时间窗: Post-cue baseline,5 minutes

Participants completed a nicotine craving assessment consisting of following five items: I have a desire for a cigarette right now, if it were possible I would smoke right now, All I want right now is a cigarette, I have an urge for a cigarette, I crave a cigarette right now. All participants indicated their craving intensity on a pre-drawn 100 mm scale ranging from 0 (disagree) to 100 (agree). At the end of the craving assessment period, mean VAS score was measured.

次要结局

  • Change From Post-cue Baseline in Nicotine Craving Score at 1 Minute(Post-cue baseline, 1 minute post treatment administration)
  • Change From Post-cue Baseline in Nicotine Craving Score at 3 Minutes(Post-cue Baseline, 3 minutes post treatment administration)
  • Change From Post-cue Baseline in Nicotine Craving Score at 10 Minutes(Post-Cue Baseline, 10 minutes post treatment administration)
  • Number of Participants With Adverse Events (AEs), Treatment Related AEs, and Serious AEs (SAEs)(Baseline to Day 5 post treatment administration)
  • Change From Post-cue Baseline in Nicotine Craving Score at 7 Minutes(Post-Cue Baseline, 7 minutes post treatment administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验